SCHEMBL31240720

SCHEMBL31240720

O=C(Cc1ccccc1C(F)(F)F)Nc1cc(Cl)ccn1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RIOK2 Q9BVS4 2/20 0.57
GSK3A P49840 1/20 0.57
MAPK10 P53779 1/20 0.57
ANO1 Q5XXA6 2/20 0.54
NR3C2 P08235 1/20 0.54
CSF1R P07333 1/20 0.49
PDGFRB P09619 1/20 0.49
KIT P10721 1/20 0.49
PDGFRA P16234 1/20 0.49
FLT3 P36888 1/20 0.49
KCNJ5 P48544 2/20 0.49
KCNJ3 P48549 2/20 0.49
P2RX4 Q99571 1/20 0.47
MKNK1 Q9BUB5 1/20 0.46
NR2E1 Q9Y466 2/20 0.45
KMT2A Q03164 1/20 0.45
P2RX7 Q99572 3/20 0.44
RORA P35398 1/20 0.44
RBP4 P02753 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14156922 0.83 NR3C2 (0.53) RIOK2GSK3AMAPK10ANO1NR3C2
SCHEMBL31240626 0.81 GSK3A (0.60) RIOK2GSK3AMAPK10ANO1NR3C2
SCHEMBL30368259 0.80 ANO1 (0.66) ANO1NR3C2CSF1RPDGFRBKIT
SCHEMBL31240678 0.78 GAA (0.62) RIOK2GSK3AMAPK10ANO1NR3C2
SCHEMBL31240659 0.78 RIOK2 (0.74) RIOK2GSK3AMAPK10KMT2A
SCHEMBL31240713 0.78 RIOK2 (0.62) RIOK2GSK3AMAPK10ANO1NR3C2
SCHEMBL31240786 0.77 RIOK2 (0.62) RIOK2GSK3AMAPK10ANO1NR3C2
SCHEMBL4199348 0.76 CSF1R (0.49) ANO1CSF1RPDGFRBKITPDGFRA
SCHEMBL31240480 0.76 GSK3A (0.63) RIOK2GSK3AMAPK10ANO1KMT2A
SCHEMBL30368264 0.74 JAK2 (0.55) ANO1CSF1RPDGFRBKITPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 WO disclosed